Table 5.
Choroidal thickness recorded at baseline and at 3 and 12 months of follow up in patients with obstructive sleep apnea undergoing continuous positive airway pressure treatment.
| Baseline | 3 Months | 12 Months | P* Raw | P** Adjusted (1) (2) (3) |
|
|---|---|---|---|---|---|
| Fovea | 268.84 (±61.66) | 257.68 (±61.16) | 262.36 (±59.63) | 0.079 | 0.116 0.456 0.999 |
| Temporal | 259.75 (±65.06) | 247.52 (±59.33) | 250.73 (±60.19) | 0.007 |
0.014 0.038 0.999 |
| Nasal | 249.70 (±66.64) | 246.52 (±66.57) | 244.86 (±64.61) | 0.517 | NA |
Data expressed as the mean (±standard deviation). P* raw: significance level obtained by repeated measures ANOVA or Friedman test (according to normality of data distribution). P** adjusted: adjusted significance level obtained through post-hoc tests for multiple comparisons with Bonferroni correction. (1) Baseline vs. 3 months. (2) Baseline vs. 12 months. (3) 3 months vs. 12 months. NA: Post-hoc test not applicable for P* greater than 0.1. Values in bold indicate p < 0.05.